Dublin-based US drugmaker Alkermes has reported a 14% year-on-year increase in third-quarter net revenue to $160m (€125m), beating analyst forecasts.

Irish-American pharmaceutical company Alkermes has increased its full-year profit forecast for the second time in three months.